论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
卵巢成熟囊性畸胎瘤破裂伴腺癌转化一例报告
Authors Xu L , Jiang J, Geng Q, Zhang Y
Received 7 August 2024
Accepted for publication 16 December 2024
Published 21 December 2024 Volume 2024:16 Pages 2281—2285
DOI https://doi.org/10.2147/IJWH.S490109
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Vinay Kumar
Liping Xu, Jinxiao Jiang, Qingxia Geng, Yinmin Zhang
Department of Gynecology, Rizhao People’s Hospital, Rizhao, Shandong Province, 276800, People’s Republic of China
Correspondence: Yinmin Zhang, Department of Gynecology, Rizhao People’s Hospital, Rizhao, Shandong Province, 276800, People’s Republic of China, Tel +86 13806332079, Email 1158287283@qq.com
Purpose: Ovarian mature cystic teratoma (MCT) is the most common ovarian tumor, and only a small fraction undergoes malignant transformation. The most prevalent malignant type of the ovary is squamous cell carcinoma, followed by adenocarcinoma. However, ruptured ovarian mature cystic teratoma with adenocarcinoma transformation is extremely rare.
Case Presentation: A 75-year-old postmenopausal woman presented to the emergency room with abdominal pain following a CT examination, the patient was diagnosed with a ruptured ovarian MCT. Subsequently, surgery was performed. Finally, she was diagnosed with adenocarcinoma tumor originating from the MCT of the ovary based on histopathology and immunohistochemistry examination. Following six cycles of chemotherapy with carboplatin and paclitaxel, the patient underwent long‐term follow-up, during which no recurrence was observed over 10 months of examinations.
Conclusion: The cases of ruptured cystic teratomas are rare, and ruptured cancerous transformation in MCT is infrequently documented in the literature. Therefore, special attention should be paid when encountering such cases in medical practice, as they can easily be misdiagnosed as benign ovarian tumors.
Keywords: mature cystic teratoma, malignant transformation, squamous cell carcinoma, adenocarcinoma